Occurrence of Myopericarditis Following COVID-19 Vaccination Among Adults in the Eastern Region, Saudi Arabia: A Multicenter Study.

Eidan M Al Zahrani Salah H ElsafiRawan S AlkharrazNoureldin H SahalMohammed AlmansoriAmeen I AlhababiZeyad S Alkharraz

Published in: International journal of general medicine (2024)

We found no difference in the occurrence of myocarditis and myopericarditis after the COVID-19 vaccine compared with the background rate during a similar period (P = 0.9783). The incidences of myocarditis and myopericarditis following immunization were low. The advantages of the COVID-19 vaccination outweigh the risk of myopericarditis.

Keyphrases

coronavirus disease
sars cov
saudi arabia
risk assessment
respiratory syndrome coronavirus